Present and future challenges in the treatment of haemophilia: the patient's perspective
- PMID: 24333318
- PMCID: PMC3853977
- DOI: 10.2450/2013.013s
Present and future challenges in the treatment of haemophilia: the patient's perspective
Similar articles
-
Present and future challanges in the treatment of haemophilia: a clinician's perspective.Blood Transfus. 2013 Sep;11 Suppl 4(Suppl 4):s77-81. doi: 10.2450/2013.012s. Blood Transfus. 2013. PMID: 24333317 Free PMC article. Review. No abstract available.
-
[Life with haemophilia. The patient's perspective of ageing].Hamostaseologie. 2013;33 Suppl 1:S22-4. Hamostaseologie. 2013. PMID: 24170034 German.
-
Recent evolution of clotting factor concentrates for hemophilia A and B. Transfusion Practices Committee.Transfusion. 1993 May;33(5):422-34. doi: 10.1046/j.1537-2995.1993.33593255605.x. Transfusion. 1993. PMID: 8488548 Review. No abstract available.
-
Quality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patients.Haemophilia. 2002 Jan;8(1):44-50. doi: 10.1046/j.1365-2516.2002.00581.x. Haemophilia. 2002. PMID: 11886464
-
From the voices of people with haemophilia A and their caregivers: Challenges with current treatment, their impact on quality of life and desired improvements in future therapies.Haemophilia. 2019 May;25(3):433-440. doi: 10.1111/hae.13754. Epub 2019 Apr 23. Haemophilia. 2019. PMID: 31016823 Free PMC article.
Cited by
-
Understanding treatment burden in hemophilia: development and validation of the Hemophilia Treatment Experience Measure (Hemo-TEM).J Patient Rep Outcomes. 2023 Feb 23;7(1):17. doi: 10.1186/s41687-023-00550-6. J Patient Rep Outcomes. 2023. PMID: 36821002 Free PMC article. Review.
-
The Italian institutional accreditation model for Haemophilia Centres.Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):s510-4. doi: 10.2450/2014.0058-14s. Blood Transfus. 2014. PMID: 24922290 Free PMC article.
-
Comparing regional models of congenital bleeding disorders: preliminary steps in the Italian context.BMC Res Notes. 2017 Jun 26;10(1):229. doi: 10.1186/s13104-017-2552-6. BMC Res Notes. 2017. PMID: 28651638 Free PMC article.
-
Development and validation of the Child Hemophilia Treatment Experience Measure: A new observer-reported outcome measure.Haemophilia. 2025 Jan;31(1):48-62. doi: 10.1111/hae.15102. Epub 2024 Oct 10. Haemophilia. 2025. PMID: 39387634 Free PMC article.
-
Plasma-derived medicinal products: demand and clinical use.Blood Transfus. 2013 Sep;11 Suppl 4(Suppl 4):s2-5. doi: 10.2450/2013.002s. Blood Transfus. 2013. PMID: 24333309 Free PMC article. No abstract available.
References
-
- Bolton-Maggs PH, Pasi KJ. Haemophilia A and B. Lancet. 2003;361:1801–9. - PubMed
-
- Tagliaferri A, Rivolta GF, Iorio A, et al. Mortality and causes of death in Italian persons with haemophilia, 1990–2007. Haemophilia. 2010;16:437–46. - PubMed
-
- Coppola A, Franchini M, Tagliaferri A. Prophylaxis in people with haemophilia. Thromb Haemost. 2009;101:674–81. - PubMed
-
- Gringeri A, Lundin B, von Mackensen S, et al. A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study) J Thromb Haemost. 2011;9:700–10. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical